A Layer Plus Approach to Implementation Research and Collaboration for Long-Acting Injectable Preexposure Prophylaxis for HIV Prevention.

In 2020, the HIV prevention clinical trials, HPTN (HIV Prevention Trials Network) 083 and 084, reported that long-acting injectable cabotegravir (CAB-LA) for HIV prevention was statistically superior to daily oral tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) for pre-exposure prophylaxis (Pr...

Full description

Bibliographic Details

Published in:	Health Promotion Practice Vol. 23; no. 6; pp. 912 - 916
Main Authors:	Pilgrim, Nanlesta A., Evans, Tammeka M., Czarnogorski, Maggie
Format:	pictorial Journal Article
Published:	Sage Publications Inc. Nov2022
Online Access:	View this record in EBSCOhost